China Literature Ltd. is an investment holding company. It engages in the provision of reading services, copyright commercialization, writer cultivation and brokerage, operation of text work reading and related open platform, which are all based on text work, and the realization of these activities through technology methods and digital media including but not limited to personal computers, Internet and mobile network in the People's Republic of China. The company was founded on April 22, 2013 and is headquartered in Shanghai, China.
Novartis AG (NOVN.EB) said Tuesday that it is teaming up with scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute to develop cancer therapy systems.
Ownership may exceed 100% due to the nature and timing of public filings. Information relating
to ownership positions covers all beneficial and institutional holdings sourced form publicly
available information either written or outside of the United States.
The data on the adr.com website is delayed by at least 15 minutes. Benchmark prices are indicative
only and provided for informational purposes. All information is subject to market conditions and
may change at any time and without notice. J.P. Morgan does not undertake to update any prices or
information provided herin. Information is not intended as a recommendation nor an offer or
solicitation for the purchase or sale of any financial instrument.